Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease.

Kitada S, Uenami T, Yoshimura K, Tateishi Y, Miki K, Miki M, Hashimoto H, Fujikawa T, Mori M, Matsuura K, Kuroyama M, Maekura R.

Int J Tuberc Lung Dis. 2012 May;16(5):660-4. doi: 10.5588/ijtld.11.0534. Epub 2012 Mar 7.

PMID:
22410245
2.

Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.

Lee G, Lee KS, Moon JW, Koh WJ, Jeong BH, Jeong YJ, Kim HJ, Woo S.

Ann Am Thorac Soc. 2013 Aug;10(4):299-306. doi: 10.1513/AnnalsATS.201303-062OC.

PMID:
23952847
3.

Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.

Koyama K, Ohshima N, Kawashima M, Okuda K, Sato R, Nagai H, Matsui H, Ohta K.

Respir Med. 2015 Oct;109(10):1347-53. doi: 10.1016/j.rmed.2015.08.016. Epub 2015 Aug 30.

4.

Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.

Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Am J Respir Crit Care Med. 2015 Jan 1;191(1):96-103. doi: 10.1164/rccm.201408-1545OC.

PMID:
25393520
5.

Bronchoscopic microsampling for bacterial colony counting in relevant lesions in patients with pulmonary Mycobacterium avium complex infection.

Ushiki A, Yamazaki Y, Koyama S, Tsushima K, Yamamoto H, Hanaoka M, Kubo K.

Intern Med. 2011;50(12):1287-92. Epub 2011 Jun 15.

6.

Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.

Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, Wilson R, Graviss EA, Wallace RJ Jr.

Am J Respir Crit Care Med. 2006 Oct 15;174(8):928-34. Epub 2006 Jul 20.

PMID:
16858014
7.

Risk factors for deterioration of nodular bronchiectatic Mycobacterium avium complex lung disease.

Kim SJ, Park J, Lee H, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH.

Int J Tuberc Lung Dis. 2014 Jun;18(6):730-6. doi: 10.5588/ijtld.13.0792.

PMID:
24903946
8.

Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.

Wallace RJ Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE.

Chest. 2014 Aug;146(2):276-282. doi: 10.1378/chest.13-2538.

9.

Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.

Moon SM, Park HY, Kim SY, Jhun BW, Lee H, Jeon K, Kim DH, Huh HJ, Ki CS, Lee NY, Kim HK, Choi YS, Kim J, Lee SH, Kim CK, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6758-6765. doi: 10.1128/AAC.01240-16. Print 2016 Nov.

10.

Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.

Gochi M, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y.

BMJ Open. 2015 Aug 5;5(8):e008058. doi: 10.1136/bmjopen-2015-008058.

11.

Consolidations in nodular bronchiectatic Mycobacterium avium complex lung disease: Mycobacterium avium complex or other infection?

Im SA, Park HJ, Park SH, Chun HJ, Jung WS, Kim SH.

Yonsei Med J. 2010 Jul;51(4):546-51. doi: 10.3349/ymj.2010.51.4.546.

12.

Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.

Ramirez J, Mason C, Ali J, Lopez FA.

J La State Med Soc. 2008 Sep-Oct;160(5):248-54; quiz 254, 293.

PMID:
19048978
13.

[Clinical study on development of nontuberculous mycobacterial lung disease].

Kurashima A.

Kekkaku. 2004 Dec;79(12):737-41. Review. Japanese.

PMID:
15782619
14.

Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.

Watanabe M, Hasegawa N, Ishizaka A, Asakura K, Izumi Y, Eguchi K, Kawamura M, Horinouchi H, Kobayashi K.

Ann Thorac Surg. 2006 Jun;81(6):2026-30.

PMID:
16731124
15.

Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.

Komiya K, Kurashima A, Ihi T, Nagai H, Matsumoto N, Mizunoe S, Ishii H, Takahashi O, Ohta K, Kudoh S, Kadota J.

Int J Antimicrob Agents. 2014 Aug;44(2):131-5. doi: 10.1016/j.ijantimicag.2014.03.017. Epub 2014 Jun 2.

PMID:
24948577
16.

Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease.

Griffith DE, Adjemian J, Brown-Elliott BA, Philley JV, Prevots DR, Gaston C, Olivier KN, Wallace RJ Jr.

Am J Respir Crit Care Med. 2015 Sep 15;192(6):754-60. doi: 10.1164/rccm.201503-0444OC.

17.

Serial CT findings of nodular bronchiectatic Mycobacterium avium complex pulmonary disease with antibiotic treatment.

Lee G, Kim HS, Lee KS, Koh WJ, Jeon K, Jeong BH, Ahn J.

AJR Am J Roentgenol. 2013 Oct;201(4):764-72. doi: 10.2214/AJR.12.9897.

PMID:
24059365
18.
19.

Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Park IK, Olivier KN.

Semin Respir Crit Care Med. 2015 Apr;36(2):217-24. doi: 10.1055/s-0035-1546751. Epub 2015 Mar 31. Review.

PMID:
25826589
20.

Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease.

Lee BY, Kim S, Hong Y, Lee SD, Kim WS, Kim DS, Shim TS, Jo KW.

Antimicrob Agents Chemother. 2015;59(6):2972-7. doi: 10.1128/AAC.04577-14. Epub 2015 Mar 9.

Supplemental Content

Support Center